Xavier Valencia

Xavier Valencia currently serves as the Senior Vice President and Head of Clinical Development at Ventus Therapeutics since October 2023. Prior to this role, Xavier led clinical development at Tr1X, focusing on cellular therapies aimed at curing autoimmune and inflammatory diseases from March to October 2023. Xavier's extensive experience includes serving as Head of Clinical Development at Capella Bioscience, a Centessa Company, from November 2021 to March 2023, and at Design Therapeutics from February to November 2021. Previously, Xavier held the position of Vice President and Head of Research & Development at Strongbridge Biopharma plc from September 2019 to February 2021.